- S
SUBSTIPHARM
- Jean-Mathieu Bellanger
Jean-Mathieu Bellanger has a diverse background in finance and auditing, with experience at companies such as SUBSTIPHARM, June Partners, EY, and GLASSOLUTIONS Saint-Gobain. Jean-Mathieu has expertise in areas such as financial analysis, process review, reporting, project management, and development of skills in data analytics. Jean-Mathieu holds a Master's degree in Audit et contrôle de gestion from Grenoble Ecole de Management and has additional education in economics and management from Czech University of Life Science.
Org chart
Teams
This person is not in any teams
Offices
SUBSTIPHARM
Substipharm is a privately held pharmaceutical Group. We develop, supply and commercialize pharmaceuticals in more than 60 countries worldwide. Our portfolio of products that we currently license out or distribute directly or through partners comprises more than 60 different molecules. Our development pipeline includes as well more than 40 ongoing projects. We have a successful portfolio of pharmaceutical products and vaccines including: Mature brands Generics Over the counter (OTC) pharmaceuticals Difficult to develop medicines Value added presentations Biological products including vaccines:
